Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Allstate Corporation stock logo
ALL
Allstate
$196.92
-1.7%
$200.99
$176.00
$214.76
$51.89B0.371.69 million shs1.51 million shs
Rio2 Limited stock logo
ATM
Rio2
C$0.68
+1.5%
C$0.68
C$0.57
C$0.86
C$57.62MN/A114,654 shs15,000 shs
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$9.35
+1.1%
$7.88
$1.92
$11.60
$493.87M2.44449,804 shs260,877 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Allstate Corporation stock logo
ALL
Allstate
0.00%-0.49%-3.07%+0.50%+6.43%
Rio2 Limited stock logo
ATM
Rio2
0.00%0.00%0.00%0.00%0.00%
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
0.00%-12.07%-12.49%+147.33%+241.33%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
The Allstate Corporation stock logo
ALL
Allstate
$196.92
-1.7%
$200.99
$176.00
$214.76
$51.89B0.371.69 million shs1.51 million shs
Rio2 Limited stock logo
ATM
Rio2
C$0.68
+1.5%
C$0.68
C$0.57
C$0.86
C$57.62MN/A114,654 shs15,000 shs
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
$9.35
+1.1%
$7.88
$1.92
$11.60
$493.87M2.44449,804 shs260,877 shs
The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
The Allstate Corporation stock logo
ALL
Allstate
0.00%-0.49%-3.07%+0.50%+6.43%
Rio2 Limited stock logo
ATM
Rio2
0.00%0.00%0.00%0.00%0.00%
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
0.00%-12.07%-12.49%+147.33%+241.33%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
The Allstate Corporation stock logo
ALL
Allstate
2.76
Moderate Buy$231.2117.42% Upside
Rio2 Limited stock logo
ATM
Rio2
0.00
N/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
2.00
Hold$11.7525.67% Upside

Current Analyst Ratings Breakdown

Latest PREM, ALL, ATM, and KOD Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/20/2025
The Allstate Corporation stock logo
ALL
Allstate
BMO Capital Markets
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$230.00 ➝ $235.00
8/18/2025
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetNeutral$3.00 ➝ $5.00
8/14/2025
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
Barclays
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetUnderweight$4.00 ➝ $7.00
8/14/2025
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeUnderweightNeutral$15.00
8/13/2025
The Allstate Corporation stock logo
ALL
Allstate
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
8/13/2025
The Allstate Corporation stock logo
ALL
Allstate
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeHold
8/12/2025
The Allstate Corporation stock logo
ALL
Allstate
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageNeutral$202.00
8/11/2025
The Allstate Corporation stock logo
ALL
Allstate
Jefferies Financial Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$254.00 ➝ $255.00
8/6/2025
The Allstate Corporation stock logo
ALL
Allstate
Keefe, Bruyette & Woods
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetOutperform$237.00 ➝ $246.00
8/5/2025
The Allstate Corporation stock logo
ALL
Allstate
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price TargetEqual Weight$197.00 ➝ $202.00
8/4/2025
The Allstate Corporation stock logo
ALL
Allstate
Raymond James Financial
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingStrong-Buy$250.00 ➝ $260.00
(Data available from 9/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
The Allstate Corporation stock logo
ALL
Allstate
$66.21B0.78$20.71 per share9.51$73.13 per share2.69
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/AN/AN/AN/A$2.86 per shareN/A
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
The Allstate Corporation stock logo
ALL
Allstate
$4.67B$21.279.269.140.808.79%28.74%5.05%10/29/2025 (Estimated)
Rio2 Limited stock logo
ATM
Rio2
N/AN/A0.00N/AN/AN/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$176.21M-$3.80N/AN/AN/AN/A-155.27%-63.29%11/13/2025 (Estimated)

Latest PREM, ALL, ATM, and KOD Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/13/2025Q2 2025
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
-$1.01-$1.03-$0.02-$1.03N/AN/A
7/30/2025Q2 2025
The Allstate Corporation stock logo
ALL
Allstate
$3.20$5.94+$2.74$7.76$16.59 billion$15.05 billion
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
The Allstate Corporation stock logo
ALL
Allstate
$4.002.03%N/A18.81%15 Years
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/AN/AN/AN/AN/A

Latest PREM, ALL, ATM, and KOD Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
7/15/2025
The Allstate Corporation stock logo
ALL
Allstate
quarterly$1.001.96%8/29/20258/29/202510/1/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
The Allstate Corporation stock logo
ALL
Allstate
0.37
0.43
0.43
Rio2 Limited stock logo
ATM
Rio2
N/AN/AN/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
N/A
3.48
3.48

Institutional Ownership

CompanyInstitutional Ownership
The Allstate Corporation stock logo
ALL
Allstate
76.47%
Rio2 Limited stock logo
ATM
Rio2
N/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
89.06%

Insider Ownership

CompanyInsider Ownership
The Allstate Corporation stock logo
ALL
Allstate
1.70%
Rio2 Limited stock logo
ATM
Rio2
N/A
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
45.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
The Allstate Corporation stock logo
ALL
Allstate
55,400263.51 million259.03 millionOptionable
Rio2 Limited stock logo
ATM
Rio2
N/A84.74 millionN/ANot Optionable
Kodiak Sciences Inc. stock logo
KOD
Kodiak Sciences
9052.82 million28.58 millionOptionable

Recent News About These Companies

Kodiak Sciences (NASDAQ:KOD) Trading Down 5.4% - Should You Sell?
Kodiak Sciences Inc. $KOD Shares Sold by Invesco Ltd.
Brokers Offer Predictions for Kodiak Sciences Q3 Earnings
Nuveen LLC Buys New Shares in Kodiak Sciences Inc. $KOD
Analysts Set Expectations for Kodiak Sciences Q3 Earnings
Harbour BioMed Reports 2025 Interim Results
Cramer's Lightning Round: Oklo is a buy

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Allstate stock logo

Allstate NYSE:ALL

$196.92 -3.47 (-1.73%)
Closing price 03:59 PM Eastern
Extended Trading
$198.98 +2.06 (+1.05%)
As of 05:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments. The Allstate Protection segment offers private passenger auto and homeowners insurance; other personal lines products; and commercial lines products through agents, contact centers, and online. The Protection Services segment provides consumer product protection; protection and insurance products, including vehicle service contracts, guaranteed asset protection, road hazard tire and wheel, and paintless dent repair protection; and roadside assistance, device and mobile data collection services, and analytic solutions using automotive telematics information, as well as identity theft protection and remediation services. This segment also offers its products under various brands, including Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, Avail, and Allstate Identity Protection. The Allstate Health and Benefits segment provides life, accident, critical illness, short-term disability, and other health insurance products; stop-loss and fully insured group health products to employers; and short-term medical and medicare supplement insurance to individuals. The Run-off Property-Liability segment offers property and casualty insurance coverage that primarily relates to policies written during the 1960s through the mid-1980s. The Corporate and Other segment provides debt services, as well as non-insurance operations. It sells its products through agents, independent agents, call and contact centers, retailers, direct to consumer, wholesale partners, and affinity groups, as well as through online and mobile applications. The Allstate Corporation was founded in 1931 and is headquartered in Northbrook, Illinois.

Rio2 stock logo

Rio2 CVE:ATM

C$0.68 +0.01 (+1.49%)
As of 07/26/2018

Atacama Pacific Gold Corporation, an exploration stage company, engages in the acquisition, exploration, and development of gold properties in Chile. The company principally holds a 100% interest in the Cerro Maricunga gold project located in Region III northeast of the city of Copiapo. Atacama Pacific Gold Corporation was incorporated in 2008 and is headquartered in Toronto, Canada.

Kodiak Sciences stock logo

Kodiak Sciences NASDAQ:KOD

$9.35 +0.10 (+1.08%)
Closing price 04:00 PM Eastern
Extended Trading
$9.54 +0.19 (+1.98%)
As of 05:25 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is tarcocimab tedromer (KSI-301), an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as well as Phase III clinical study for the treatment of diabetic macular edema, naïve macular edema due to retinal vein occlusion, and non-proliferative diabetic retinopathy. The company's preclinical stage product candidate includes KSI-501, a bispecific conjugate to treat retinal diseases with an inflammatory component; and KSI-601, a triplet biopolymer conjugate for the treatment of dry AMD. The company was formerly known as Oligasis, LLC and changed its name to Kodiak Sciences Inc. in September 2015. Kodiak Sciences Inc. was incorporated in 2009 and is based in Palo Alto, California.